InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,870.62
(
-1.32%
)
US TECH 100
19,880.00
(
-2.30%
)
Dow Jones
43,444.99
(
-0.70%
)
Brent Oil
71.25
(
0.00%
)
Bitcoin
90,532.05
(
-0.06%
)
Post# of 3274
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

ThePennyDoctor

Send PM Follow Ignore
Followers 143
Posts 2560
Boards Moderated 1
Alias Born 01/26/2013

ThePennyDoctor

Re: kkpm post# 2722

Wednesday, 10/09/2013 9:16:10 PM

Wednesday, October 09, 2013 9:16:10 PM

Post# of 3274
Keep an eye on ACAD - it has taken the biggest beating in the last 2 days. Should bounce at some point.

----------------

From Monday - Acadia Pharma -18% on rumor but no hard news

Acadia Pharmaceuticals (ACAD -17.9%) shares are down sharply, with no recent news or information to account for the move, though biotech blogger Adam Feuerstein tweets a rumor that today's decline is due to a doctor on a Cowen panel having a bearish stance on its lead drug candidate pimavanserin.
Pimavanserin is in Phase 3 development as a potential first-in-class treatment for Parkinson's disease psychosis, and ACAD established an expedited path to an NDA filing in Q2.
Shares are up 403% YTD.

Whoever loves money never has money enough; whoever loves wealth is never satisfied with his income. I have seen all the things that are done under the sun; all of them are meaningless, a chasing after the wind. Only trade for the sake of trading.

Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up